Genmab (GE91) Ownership - Who Owns Genmab?
Genmab (GE91) Ownership Overview
- 0.71% Mutual Funds
- 0.16% Other Institutional Investors
- 1.30% ETFs
- 97.82% Public Companies and Individual Investors
The ownership structure of Genmab (DE:GE91) stock is a mix of institutional, retail, and individual investors. Approximately 2.18% of the company’s stock is owned by Institutional Investors, and 97.82% is owned by Public Companies and Individual Investors.
The ownership structure of Genmab (DE:GE91) stock is a mix of institutional, retail, and individual investors. Approximately 2.18% of the company’s stock is owned by Institutional Investors, and 97.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Manning & Napier Advisors Llc | €2,217 | |
| Dec 31, 2025 | Gallacher Capital Management Llc | €664,202 | |
| Dec 31, 2025 | Woodline Partners Lp | €11,370,990 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| James E. Flynn | 6,865,000 | Institution | 1.10% | 384,632,220 |
| Ishares | 4,505,031 | Institution | 0.72% | 252,407,877 |
| First Trust | 2,728,596 | Institution | 0.44% | 152,877,777 |
| Ab Large Cap Growth Fund Inc | 1,692,412 | Institution | 0.27% | 94,822,460 |
| Federated Hermes Equity Funds | 870,700 | Institution | 0.14% | 48,783,580 |
| Avantis | 549,657 | Institution | 0.09% | 30,796,182 |
| Russell Investment Co | 446,637 | Institution | 0.07% | 25,024,178 |
| Louis Moore Bacon | 420,487 | Institution | 0.07% | 23,559,046 |
| Delaware Group Equity Funds Iv | 362,815 | Institution | 0.06% | 20,327,799 |
| Federated Hermes World Investment Series, Inc. | 343,771 | Institution | 0.06% | 19,260,802 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ab Large Cap Growth Fund Inc | 1,692,412 | Institution | 0.27% | 94,822,460 |
| Federated Hermes Equity Funds | 870,700 | Institution | 0.14% | 48,783,580 |
| Russell Investment Co | 446,637 | Institution | 0.07% | 25,024,178 |
| Delaware Group Equity Funds Iv | 362,815 | Institution | 0.06% | 20,327,799 |
| Federated Hermes World Investment Series, Inc. | 343,771 | Institution | 0.06% | 19,260,802 |
| Mercer Funds | 179,676 | Institution | 0.03% | 10,066,887 |
| Sei Institutional Managed Trust | 155,587 | Institution | 0.02% | 8,717,228 |
| Timothy Plan | 137,000 | Institution | 0.02% | 7,675,836 |
| Fidelity Concord Street Trust | 60,288 | Institution | <0.01% | 3,377,816 |
| Columbia Funds Series Trust I | 47,510 | Institution | <0.01% | 2,661,890 |
FAQ
What percentage of Genmab (DE:GE91) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.18% of Genmab (DE:GE91) stock is held by institutional investors: 0.71% by mutual funds, 1.30% by ETFs and 0.16% by other institutional investors.
What percentage of Genmab (DE:GE91) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.82% of Genmab (DE:GE91) stock is held by public companies and individual investors.
Who owns the most shares of Genmab (DE:GE91)?
James E. Flynn owns the most shares of Genmab (DE:GE91).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.